Asensus Surgical, Inc. to Participate in Three Upcoming Virtual Healthcare Conferences

Rhea-AI Summary

Asensus Surgical, Inc. (ASXC) announced that Anthony Fernando, CEO, and Shameze Rampertab, CFO, will present at three virtual investor conferences. The events include:

• H.C. Wainwright 23rd Annual Global Investment Conference: Recorded presentation available from September 13, 2021.
• Baird 2021 Global Healthcare Conference: Live presentation on September 14, 2021, at 2:35 PM ET.
• 2021 Cantor Virtual Global Healthcare Conference: Live presentation on September 28, 2021, at 1:20 PM ET.

Webcasts will be accessible on the company's investor relations page.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at three upcoming virtual investor conferences:

• H.C. Wainwright 23rd Annual Global Investment Conference

Recorded presentation available for on-demand listening beginning Monday, September 13, 2021, at 7:00 am Eastern Time

Presentation Format: Fireside Chat

• Baird 2021 Global Healthcare Conference

Virtual live presentation on Tuesday, September 14, 2021 at 2:35 pm Eastern Time

Presentation Format: Formal

• 2021 Cantor Virtual Global Healthcare Conference

Virtual live presentation on Tuesday, September 28, 2021 at 1:20 pm Eastern Time

Presentation Format: Formal

Webcasts of Asensus Surgical’s presentations will be available online at the investor relations page of the Company’s website at http://ir.asensus.com/events.cfm. Replays of the webcasts will be archived on the website for approximately 90 days.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210908005376/en/

INVESTOR CONTACT:

Mark Klausner or Mike Vallie, 443-213-0499

invest@asensus.com

or

MEDIA CONTACT:

Kristin Schaeffer

CG Life

kschaeffer@cglife.com

Source: Asensus Surgical, Inc.

FAQ

What are the dates for Asensus Surgical's upcoming investor conferences?

Asensus Surgical will present at the following conferences: H.C. Wainwright on September 13, 2021, Baird on September 14, 2021, and Cantor on September 28, 2021.

What format will the Asensus Surgical presentations take?

The presentations will include a recorded format for H.C. Wainwright, and live formal presentations for Baird and Cantor.

Where can I watch the Asensus Surgical presentations?

Webcasts of the presentations will be available on Asensus Surgical's investor relations page at their website.

Who will be presenting for Asensus Surgical at the conferences?

Anthony Fernando, President and CEO, and Shameze Rampertab, Executive VP and CFO, will be presenting.

What is the stock symbol for Asensus Surgical?

The stock symbol for Asensus Surgical is ASXC.